P1889
Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control studyLow levels of HIV test coverage in clinical settings in the U.K.: a systematic review of adherence to 2008 guidelinesExpanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDSGenetics of susceptibility to human infectious diseaseThe effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicityTreatment outcomes of treatment-naïve Hepatitis C patients co-infected with HIV: a systematic review and meta-analysis of observational cohortsA coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection.Renal impairment in a rural African antiretroviral programme.Need for timely paediatric HIV treatment within primary health care in rural South Africa.Treatment of cryptococcal meningitis in KwaZulu-Natal, South Africa.The tuberculosis challenge in a rural South African HIV programme.Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound.Population uptake of antiretroviral treatment through primary care in rural South Africa.Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes?Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact.B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection.Technologies for global health.Hepatitis B Co-Infection is Associated with Poorer Survival of HIV-Infected Patients on Highly Active Antiretroviral Therapy in West AfricaGlobal distribution and prevalence of hepatitis C virus genotypes.Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa.Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study.International spread of MDR TB from Tugela Ferry, South Africa.Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohortImpact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial.Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis.T-cell immunophenotyping distinguishes active from latent tuberculosisTracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapyLocalized spatial clustering of HIV infections in a widely disseminated rural South African epidemicAdult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa.Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review.Treatment for hepatitis B.Update on tuberculosis: TB in the early 21st century.Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis.Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease.Impact of Point-of-care Xpert MTB/RIF on Tuberculosis Treatment Initiation: A Cluster Randomised Trial.Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice.A comparison between two strategies for monitoring hepatic function during antituberculous therapy.F-18 FDG PET in the diagnosis and monitoring of salmonella vertebral osteomyelitis: a comparison with MRI.British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013.
P50
Q21144235-F48DB507-A245-4E1D-A0F8-794FA206251BQ26995231-919BADE7-7299-45FB-9707-982E8F3687FAQ27004509-76767230-F2D3-4427-867A-140511069FF1Q28208872-B736733B-68B5-4B76-9909-2C1FC502C7BCQ28483688-236D6943-E549-46B4-9B47-89C597CC8258Q28485972-D0EE9B15-9365-4F16-9DA1-6BDF89F971F0Q33241396-2798EDA3-CA26-4157-84A1-DFBFFC0DAF05Q33498149-5D2C9254-CAFB-4A8C-9E3B-4288D0926EBCQ33505672-F7B580CD-1D06-457C-9DB7-D70810D45F25Q33523050-61F5E083-265C-42E8-A9B9-C960325D9777Q33530558-FA68C1CB-AD88-4CAE-BCBA-E0E637003EFBQ33640495-A1F7C284-D148-4157-86AA-18DF5FFFA5F1Q33709954-9B709E3C-D482-43D0-80FA-97B34AEF0F77Q34015581-13940634-B6AF-410E-AA9C-5D8D81DA0F1EQ34224000-54F98636-BB09-4409-86CE-BFCD40C92EFEQ34239109-B00815FF-7B14-4775-A95D-22E10CC35940Q34291969-B024B644-A68F-463E-9A51-6A601F94E08AQ34349330-76C4876E-4C90-42EC-A37E-68D319975B25Q34431175-24D3D3AA-2ABE-4C5A-8BB0-DAC63FF206F1Q34776408-9C3F8DD5-7298-48A8-A12B-70E1565F8F93Q35800557-E07F91C9-DEFC-4F2F-B67C-797C8ED6F3C8Q35847213-6D0C5923-2BD3-47BC-8E97-A20D0C69E39BQ36699205-8D91BBDF-EEE6-4610-9F62-0DCAF3B325F5Q36940706-735663B2-1FE6-458F-B9FB-BC72B85BBE8FQ37098469-D6045A7F-A6AB-4498-B2F7-7C69F1557380Q37109528-E680C2BF-7CCF-4D97-99A2-2F23747497C2Q37225313-78262EBD-D05C-4906-B5D2-EE889FCD7356Q37287966-BEEBD2BB-A251-41F5-B257-772B052D114EQ37370827-12FB8A22-3D25-4F82-A12B-521647FA5F7CQ37501613-013D0A5E-2ABF-47F6-8A81-9082699D85B5Q37668879-6DB6B492-2BDF-4ACC-B5E2-C4467D743EF5Q37883790-51BF04CA-EC58-43ED-AE00-42B0F99C9323Q38051262-6A57A068-1792-4E16-97E1-135862D3E1F6Q38065028-154AF5C8-9A32-47A7-B3EC-2C04356BF7BCQ38879178-0686B674-CE9F-4937-9B85-48CACBBD441AQ39172214-253AFE3B-03BE-4E62-9ADE-41BF5619129FQ39742683-C431D42F-A8EB-448E-952B-87CE20B50B12Q40013706-13E2A8BC-F01E-4C60-B569-C0C3A92D2304Q40476307-8DEA06B7-7077-4575-B025-3154B33F1F40Q42234629-A7B1614F-63A8-406F-8BFC-A7AFB269D2F1
P50
description
NIHR Professor of Infectious D ...... ute of Imperial College London
@en
name
Graham Cooke
@ast
Graham Cooke
@en
Graham Cooke
@es
Graham Cooke
@nl
type
label
Graham Cooke
@ast
Graham Cooke
@en
Graham Cooke
@es
Graham Cooke
@nl
prefLabel
Graham Cooke
@ast
Graham Cooke
@en
Graham Cooke
@es
Graham Cooke
@nl
P1889
P21
P31
P496
0000-0001-6475-5056